NDAINJECTIONINJECTABLEPriority Review
Approved
Mar 1984
Lifecycle
LOE Approaching
Competitive Pressure
60/100
Clinical Trials
2
Data completeness
3/8 — Basic
Priority Review
Drug data last refreshed 16m ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
DDAVP (desmopressin acetate) is a synthetic vasopressin analog administered by injection used to treat diabetes insipidus, nocturnal enuresis, and hemophilia A/von Willebrand disease. It works by mimicking antidiuretic hormone (ADH) to increase water reabsorption in the kidneys and enhance clotting factor release.
LOE Approaching
Product approaching loss of exclusivity with moderate competitive pressure (60%) signals defensive positioning and potential team restructuring ahead.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (2)
The Effect of Combined Systematized Behavioural Modification Education Program (SyBeMeP) With DDAVP in Patients With Nocturia
Started Apr 2012
124 enrolled
Nocturia
Desmopressin Acetate 0.2 mg Tablets, Fasting
Started Jul 2003
48 enrolled
Healthy
Career Relevance
Only 2 linked jobs signal minimal active hiring; roles are non-commercial (HR/organizational), indicating product team is stable or contracting. Career growth on DDAVP is limited, with opportunities concentrated in support functions rather than brand/commercial leadership.
Initiative application (Full time) (m/f/d)
Worked on DDAVP at Nordic Pharma? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.